Results for tag: "Pomalidomide"

Pomalidomide is a drug used to treat multiple myeloma and myelodysplastic syndromes, both of which are types of leukemia. It is a type of immunomodulatory drug, which works by stimulating the immune system to fight cancer cells. It is usually used in combination with other drugs, such as dexamethasone or lenalidomide. It is taken orally, usually once a day. Common side effects include fatigue, nausea, and anemia. Pomalidomide is a relatively new drug, having been approved by the US Food and Drug Administration in 2013. It is used as a second-line treatment for multiple myeloma, when other treatments have failed. It is also used to treat myelodysplastic syndromes, a type of pre-leukemia. The pomalidomide market is growing, as it is becoming increasingly used to treat multiple myeloma and myelodysplastic syndromes. It is expected to continue to grow in the coming years, as more patients are diagnosed with these types of leukemia. Some companies in the pomalidomide market include Celgene Corporation, Bristol-Myers Squibb, and Novartis. Show Less Read more